Fibronectin as a Marker of Disease Severity in Critically Ill COVID-19 Patients

Fibronectin as a Marker of Disease Severity in Critically Ill COVID-19 Patients

The SARS-CoV-2 virus alters the expression of genes for extracellular matrix proteins, including fibronectin. The aim of the study was to establish the relationship between different forms of fibronectin, such as plasma (pFN), cellular (EDA-FN), and proteolytic FN-fragments, and disease severity and...

Full description

Bibliographic Details
Main Authors: Anna Lemańska-Perek, Dorota Krzyżanowska-Gołąb, Barbara Dragan, Maciej Tyszko, Barbara Adamik
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cells
Subjects:
COVID-19
fibronectin
intensive care
mortality prediction
biomarkers
Online Access:https://www.mdpi.com/2073-4409/11/9/1566

Similar Items

Similar Items